CHRONIC NIGHTLY DOSING OF LASMIDITAN FOR MIGRAINE PREVENTION Application EP-4279132-A3 European Patent Office 06 Mar 2024
Chronic nightly dosing of lasmiditan for migraine prevention Grant AU-2019336667-B2 Australia 29 Sep 2022
CHRONIC NIGHTLY DOSING OF LASMIDITAN FOR MIGRAINE PREVENTION Application WO-2020051137-A1 World Intellectual Property Organisation (WIPO) 12 Mar 2020